Enveric Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Enveric Biosciences Stock Summary

Enveric Biosciences competes with Ocean Biomedical, Hepion Pharmaceuticals, Elevation Oncology, and Zura Bio. Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Enveric Biosciences, Inc. is headquartered in Naples, Florida. Enveric Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.

Enveric Biosciences Key Financial Ratios

Enveric Biosciences Key Balance Sheet Accounts

Enveric Biosciences Key Income Statement Accounts

Enveric Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Enveric Biosciences's current stock value. Our valuation model uses many indicators to compare Enveric Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enveric Biosciences competition to find correlations between indicators driving Enveric Biosciences's intrinsic value. More Info.Enveric Biosciences is rated # 5 in return on equity category among its peers. It also is rated # 5 in return on asset category among its peers . At present, Enveric Biosciences' Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Enveric Biosciences' earnings, one of the primary drivers of an investment's value.

Enveric Biosciences Systematic Risk

Today, most investors in Enveric Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Enveric Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Enveric Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Enveric Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Enveric Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Enveric Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Enveric Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Enveric Biosciences's daily price indicators and compare them against related drivers.

When running Enveric Biosciences' price analysis, check to measure Enveric Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enveric Biosciences is operating at the current time. Most of Enveric Biosciences' value examination focuses on studying past and present price action to predict the probability of Enveric Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enveric Biosciences' price. Additionally, you may evaluate how the addition of Enveric Biosciences to your portfolios can decrease your overall portfolio volatility.